Fumitoshi Terauchi

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi et al. · The Lancet Oncology · 2013 · 481 citations

Medicine, Gynecology, Oncology +13

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Toru Sugiyama, Aikou Okamoto, Takayuki Enomoto et al. · Journal of Clinical Oncology · 2016 · 144 citations

Medicine, Gynecology, Oncology +15

Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer

Koji Yamazawa, Masaru Hirai, Atsuya Fujito et al. · Human Reproduction · 2007 · 142 citations · Full text

Medicine, Oncology, Pathology +17

Profiling analysis of circulating microRNA expression in cervical cancer

Yuzo Nagamitsu, Hirotaka Nishi, Toru Sasaki et al. · Molecular and Clinical Oncology · 2016 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +16

Randomized phase III trial of conventional paclitaxel and carboplatin (c-TC) versus dose dense weekly paclitaxel and carboplatin (dd-TC) in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: Japanese Gynecologic Oncology

Seiji Isonishi, Makoto Yasuda, Fumiaki Takahashi et al. · Journal of Clinical Oncology · 2008 · 37 citations

Medicine, Oncology, Pharmacotherapy +14